Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Hashimoto, D. [1 ]
Satoi, S. [1 ]
Yamamoto, T. [1 ]
Yamaki, S. [1 ]
Hirooka, S. [1 ]
Ishida, M. [1 ]
Ikeura, T. [1 ]
Sekimoto, M. [1 ]
机构：
[1] Kansai Med Univ, Hirataka, Japan
来源：
PANCREAS | 2021年 / 50卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1064 / 1064
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant therapy for resectable pancreatic cancer
    Sheikh Hasibur Rahman
    Robin Urquhart
    Michele Molinari
    [J]. World Journal of Gastrointestinal Oncology, 2017, (12) : 457 - 465
  • [32] Venous Thromboembolism Prophylaxis During Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer-Is it indicated?
    Krepline, Ashley N.
    Christians, Kathleen K.
    George, Ben
    Ritch, Paul S.
    Erickson, Beth A.
    Tolat, Parag
    Evans, Douglas B.
    Tsai, Susan
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (05) : 581 - 586
  • [33] Neoadjuvant therapy for resectable pancreatic cancer
    Rahman, Sheikh Hasibur
    Urquhart, Robin
    Molinari, Michele
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (12) : 457 - 465
  • [34] Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
    Cloyd, Jordan M.
    Heh, Victor
    Pawlik, Timothy M.
    Ejaz, Aslam
    Dillhoff, Mary
    Tsung, Allan
    Williams, Terence
    Abushahin, Laith
    Bridges, John F. P.
    Santry, Heena
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [35] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    [J]. UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [36] Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
    Wolff, Robert A.
    [J]. CURRENT DRUG TARGETS, 2012, 13 (06) : 781 - 788
  • [37] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    [J]. Updates in Surgery, 2016, 68 : 235 - 239
  • [38] Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
    Del Chiaro, Marco
    Valente, Roberto
    Arnelo, Urban
    [J]. JAMA SURGERY, 2017, 152 (11) : 1057 - 1057
  • [39] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [40] Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer
    Akhil Chawla
    George Molina
    Linda M. Pak
    Michael Rosenthal
    Joseph D. Mancias
    Thomas E. Clancy
    Brian M. Wolpin
    Jiping Wang
    [J]. Annals of Surgical Oncology, 2020, 27 : 1191 - 1200
12345